These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30150707)

  • 21. Microarray analysis of blood microvessels from PDGF-B and PDGF-Rbeta mutant mice identifies novel markers for brain pericytes.
    Bondjers C; He L; Takemoto M; Norlin J; Asker N; Hellström M; Lindahl P; Betsholtz C
    FASEB J; 2006 Aug; 20(10):1703-5. PubMed ID: 16807374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent advances in pericytes angiogenic signaling pathways].
    Lu WB; Shi XR; Xiu RJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):423-6. PubMed ID: 21914358
    [No Abstract]   [Full Text] [Related]  

  • 23. Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling.
    Nikolakopoulou AM; Zhao Z; Montagne A; Zlokovic BV
    PLoS One; 2017; 12(4):e0176225. PubMed ID: 28441414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression.
    Wang W; Qi L; Tan M; Zhang Z; Du J; Wei X; Yao X
    Urol Oncol; 2015 Apr; 33(4):168.e17-27. PubMed ID: 25766258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
    Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
    Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role for VEGF as a negative regulator of pericyte function and vessel maturation.
    Greenberg JI; Shields DJ; Barillas SG; Acevedo LM; Murphy E; Huang J; Scheppke L; Stockmann C; Johnson RS; Angle N; Cheresh DA
    Nature; 2008 Dec; 456(7223):809-13. PubMed ID: 18997771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial PDGF-D contributes to neurovascular protection after ischemic stroke by rescuing pericyte functions.
    Bernard M; Menet R; Lecordier S; ElAli A
    Cell Mol Life Sci; 2024 May; 81(1):225. PubMed ID: 38769116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors.
    Abramsson A; Lindblom P; Betsholtz C
    J Clin Invest; 2003 Oct; 112(8):1142-51. PubMed ID: 14561699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated PDGF-BB from Bone Impairs Hippocampal Vasculature by Inducing PDGFRβ Shedding from Pericytes.
    Liu G; Wang J; Wei Z; Fang CL; Shen K; Qian C; Qi C; Li T; Gao P; Wong PC; Lu H; Cao X; Wan M
    Adv Sci (Weinh); 2023 Jul; 10(20):e2206938. PubMed ID: 37102631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits Neovascularization.
    Dubrac A; Genet G; Ola R; Zhang F; Pibouin-Fragner L; Han J; Zhang J; Thomas JL; Chedotal A; Schwartz MA; Eichmann A
    Circulation; 2016 Jan; 133(4):409-21. PubMed ID: 26659946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sipjeondaebo-tang, a traditional herbal formula, inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy.
    Lee YM; Kim CS; Sohn E; Jo K; Lim HR; Kim SK; Kim JS; Kim J
    Tohoku J Exp Med; 2014 Nov; 234(3):229-36. PubMed ID: 25365937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy?
    Durham JT; Dulmovits BM; Cronk SM; Sheets AR; Herman IM
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3441-59. PubMed ID: 26030100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible involvement of basic FGF in the upregulation of PDGFRβ in pericytes after ischemic stroke.
    Nakamura K; Arimura K; Nishimura A; Tachibana M; Yoshikawa Y; Makihara N; Wakisaka Y; Kuroda J; Kamouchi M; Ooboshi H; Kitazono T; Ago T
    Brain Res; 2016 Jan; 1630():98-108. PubMed ID: 26569132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nck1, But Not Nck2, Mediates Disturbed Flow-Induced p21-Activated Kinase Activation and Endothelial Permeability.
    Alfaidi M; Bhattarai U; Orr AW
    J Am Heart Assoc; 2020 Jun; 9(11):e016099. PubMed ID: 32468886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDGF receptor β signaling in pericytes following ischemic brain injury.
    Arimura K; Ago T; Kamouchi M; Nakamura K; Ishitsuka K; Kuroda J; Sugimori H; Ooboshi H; Sasaki T; Kitazono T
    Curr Neurovasc Res; 2012 Feb; 9(1):1-9. PubMed ID: 22272762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of platelet-derived growth factor receptor β in fibrosis through extracellular matrix protein production after ischemic stroke.
    Makihara N; Arimura K; Ago T; Tachibana M; Nishimura A; Nakamura K; Matsuo R; Wakisaka Y; Kuroda J; Sugimori H; Kamouchi M; Kitazono T
    Exp Neurol; 2015 Feb; 264():127-34. PubMed ID: 25510317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling.
    Kano MR; Morishita Y; Iwata C; Iwasaka S; Watabe T; Ouchi Y; Miyazono K; Miyazawa K
    J Cell Sci; 2005 Aug; 118(Pt 16):3759-68. PubMed ID: 16105884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy.
    Enge M; Bjarnegård M; Gerhardt H; Gustafsson E; Kalén M; Asker N; Hammes HP; Shani M; Fässler R; Betsholtz C
    EMBO J; 2002 Aug; 21(16):4307-16. PubMed ID: 12169633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nck adapters are involved in the formation of dorsal ruffles, cell migration, and Rho signaling downstream of the platelet-derived growth factor beta receptor.
    Ruusala A; Pawson T; Heldin CH; Aspenström P
    J Biol Chem; 2008 Oct; 283(44):30034-44. PubMed ID: 18765673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of vessel maturation on antiangiogenic therapy in ovarian cancer.
    Lu C; Thaker PH; Lin YG; Spannuth W; Landen CN; Merritt WM; Jennings NB; Langley RR; Gershenson DM; Yancopoulos GD; Ellis LM; Jaffe RB; Coleman RL; Sood AK
    Am J Obstet Gynecol; 2008 Apr; 198(4):477.e1-9; discussion 477.e9-10. PubMed ID: 18395047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.